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Abstract. Objective and Design:We expressed soluble rat
ICAM-1, generated a polyclonal anti-ICAM-1 antibody, and
studied ICAM-1 upregulation in lung inflammatory condi-
tions. Bacterial and baculovirus expression systems were
employed.
Material: 250 g adult, male Long Evans rats were used. For
in vitro studies, rat pulmonary artery endothelial cells
(RPAEC), rat alveolar macrophages and aortic rings were
stimulated (as described below) and evaluated for ICAM-1
expression.
Treatment:RPAEC and macrophages were stimulated with
lipopolysaccharide (LPS) and recombinant murine tumour
necrosis factora (TNFa). In vivo immunoglobulin G (IgG)
immune complex-induced lung injury was employed.
Methods: Enzyme-linked immunoassay (ELISA) Western
and Northern blot analyses and immunohistochemical
evaluations were performed. All experiments were done at
least in duplicate. Data were analyzed by two-tailed
Student’s t-test.
Results:ICAM-1 expression of RPAEC was time- and dose-
dependent, peaking at 6 h after LPS-stimulation. LPS and
TNFa each enhanced ICAM-1 expression on alveolar
macrophages (reaching a maximum at 2 h). In IgG immune
complex-induced lung injury, ICAM-1 mRNA isolated from
whole lung peaked at 4 h, while lung ICAM-1 protein peaked
at 6 h.
Conclusions:Quantitation of ICAM-1 expression in vitro
and in vivo suggests that ICAM-1 plays a central role in two
lung inflammatory models. Furthermore, lung ICAM-1
upregulation involves at least two cell types: vascular
endothelial cells and alveolar macrophages.
Key words: Rat ICAM-1 – Anti-ICAM-1 – Protein
expression – Lung inflammation
Introduction
The adhesion molecule ICAM-1 (CD54), a member of the
immunoglobulin superfamily, is constitutively expressed on
endothelial and epithelial cells, and to a lesser extent on
leukocytes. As shown in several lung models of pulmonary
inflammation [1–3], ICAM-1 plays a major role in leukocyte
recruitment to inflammatory sites [4]. In the animal models
employed, one of the first steps in leukocyte migration into
tissues is engagement of neutrophils with endothelial E-
selectin, which facilitates leukocyte ‘rolling’ on the activated
endothelium. This is followed by interaction of endothelial
ICAM-1 with leukocyte LFA-1 (CD11a/CD18) (and perhaps
Mac-1, (CD11b/CD18)), which induces a firm adhesion and
blocks further rolling of neutrophils. Neutrophil transmigra-
tion through the endothelium is then aided by endothelial
products such as platelet activating factor (PAF) and IL-8
or its homologues, which appear to stimulate adherent
neutrophils. In addition, endothelial platelet endothelial cell
adhesion molecule-1 (PECAM-1) facilitates leukocyte
adhesion to basolateral junctions of endothelial cells [5].
Precisely what chemotactic factors facilitate neutrophil
transmigration is still a matter under study. The extensive
studies of Wawryk et al. [6] have helped to delineate the
interactions between human ICAM-1 and leukocytes.
In order to precisely and thoroughly quantitate ICAM-1
message and protein in two lung inflammatory models, rat
ICAM-1 was cloned. Cloned DNA (cDNA) for rat ICAM-1
was used to express ICAM-1 in two different cell expression
systems and the purified product used to immunize rabbits to
generate antibody that could be used in ELISA assays, in
immunostaining methodologies, and in in vivo blocking
experiments. Since rat cDNA and recombinant rat ICAM-1
are largely unavailable, we developed these reagents and
applied them in vitro and in vivo in order to obtain detailed
information about the amounts of rat-ICAM-1 message and
protein expressed and the cell sources of rat ICAM-1. In all
of these studies, precise, quantitative endpoints were used as
indicated. The studies to be presented indicate that in the
inflamed lung there are at least two different cell sources of
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ICAM-1. Measurements of lung ICAM-1 message RNA
(mRNA) and protein provide a detailed analysis of the
response of the inflamed lung.
Materials and methods
Protein expression in the bacterial system
The cDNA from one of the selected full-length rat ICAM-1 cDNA
libraries was sequenced and compared with already published data [7].
A partial length construct of 618 bp was used, containing the ligand
binding sites for LFA-1 and Mac-1. DNA was amplified by polymerase
chain reaction (PCR) adding the primers for the expression vector.
Restriction enzyme sites,NdeI 50 andXhoI 30, were incorporated into
the following sequences: 50-CAT ATG Nde CCT CTG CCC GCC
TGG-30 and 30-TGG GAC TCG GTC GGC ACTXho GAG CTC-50.
The DNA was ligated into the pET 14b vector (Novagen Inc., Madison,
WI, USA) and closed intoE. colipLysS (Invitrogen, Inc., Carlsbad, CA,
USA). For protein expression the cells were stimulated with 0.4 mM
isopropylthiogalactoside (IPTG) (Gibco Co., Grand Island, NY,
USA) at different bacterial densities (0.6–0.8) and for different periods
(1 h–3 h) to achieve the optimal protein production. The soluble protein
was purified over a nickel column (His bind resin, Novagen, Inc.) and
eluted with several imidazole concentrations (100 mM, 200 mM,
300 mM). Dialysis in phosphate-buffered saline (PBS), pH 7.0 at 48C
was performed and the product concentrated using Centricon
Concentrators (Amicon Co., Beverly, MA, USA).
Protein expression in the baculovirus
This procedure is similar to one described previously [8–10]. Briefly,
the same template (as described above) was created for this vector but
the restriction sites were changed toXmaI 50 andBamHI 30 according to
the vector pPBac (Stratagene Inc., LaJolla, CA, USA): 50-CCC GGG
Xma CCT CTG CCC GCC TGG-30 and 30-TGG GAC TCG GTC
GGC ACT BamH CCT AGG-50 [11]. For transfection, the ICAM-1
bearing transfer vector was mixed with linear wild-type autographa
californica nuclear polyhedrosis virus (AcMNPV) and SF-21 cells
(Invitrogen Inc.) (2× 106 cells in a 60 mm plate). Three plaque
purification assays were performed. Amplification of the virus was
achieved by infecting SF-9 cells. For optimal protein expression, SF-9
cells were infected and incubated for 4 days [9, 10]. The cells and
supernatant fluids were harvested and centrifuged (1500 rpm, 10 min),
washed in 50 mM Tris/Cl (pH¼ 7:0) containing 1 mM dithiothreitol
and 250 mM sucrose, resuspended in 0.1 ml Tris/Cl (50 mM, pH 7.0),
1 mM dithiothreitol and 0.5 mM NaCl and lysed by freezing and
thawing 5 times in liquid nitrogen. DNA shearing was performed by
five passes through a 25-gauge needle. The supernatant fluids and cell
lysates were analyzed by Western blot and run over an affinity column
loaded with the polyclonal ICAM-1 antibody, followed by elution under
acidic conditions.
Western blot analysis
Characterization of proteins was performed using sodium dodecyl
sulfate/polyacrylamide gel electrophoresis (SDS/PAGE) under both
reducing and nonreducing conditions. 5ml of Laemmli buffer were
added to 20ml of protein sample and loaded on gels (7.5 or 15%). After
electrophoresis, the gels were either stained with Coomassie blue [12]
or transferred to nitrocellulose membranes (Bio Rad Inc., Hercules, CA,
USA). The membranes were blocked with 3% bovine serum albumin
(BSA) in tris-buffered saline (TBS), incubated with the murine or rabbit
ICAM-1 antibody at a dilution of 1:500 and then incubated with a
1:3000 dilution of goat anti-murine or goat anti-rabbit alkaline
phosphatase-conjugated antibody (Bio Rad Co. Inc.), followed by
color reagents A and B.
ELISA quantitation of ICAM-1 on RPAEC and alveolar
macrophages
This assay was performed as described previously [13]. Briefly, 96 well
microtiter plates were coated with 5× 106 RPAEC per well and cultured
overnight at 378C in 5% CO2. The cells were stimulated with LPS using
varying concentrations or durations. Fixation was performed with 1%
paraformaldehyde for 10 min. For each washing step, PBS supplemen-
ted with 2% heat-inactivated fetal calf serum and 1% Tween 20 was
used. After fixation, a blocking step of 5% nonfat dry milk was added.
The biotinylated polyclonal ICAM-1 antibody (Pierce Co., Rockford,
IL, USA, ImmunoPure NHS-LC-Biotinylation Kit) was used at a
dilution of 1:100 (60 min, 378C). The plate was washed three times and
streptavidin-horseradish-peroxidase was added at a concentration of
0.1mg/ml for 15 min at room temperature.
Macrophages from bronchoalveolar lavage (BAL) fluids from rat
lungs were placed into 96 well plates (5× 105 cells/well) and stimulated
with increasing concentrations of recombinant murine TNFa (5, 10, 20,
50 and 100 ng/ml). The subsequent steps were the same as described
above. A similar study was performed, using 5mg/ml LPS instead of
TNFa. The macrophages were stimulated for 2, 4, 6 and 8 h with LPS
and subsequently fixed.
Immunohistochemical and immunofluorescent analysis of rat
endothelial cells and aortic rings
RPAEC were plated at a density of 1× 105 per chamber in Lab Tek
chamber slides (Nunc Co., Naperville, IL, USA) and cultured
overnight. Cells were stimulated with the indicated concentrations of
recombinant murine TNFa (R&D Systems Inc., Minneapolis, MN,
USA) and incubated for 4 h at 378C. As a control, purified IgG was
used. The cells were then washed, fixed for 10 min in cold acetone and
incubated with the polyclonal anti-ICAM antibody or the control IgG
antibody (10mg/ml) for 60 min at room temperature. Further processing
was performed using the Vectastain biotin-avidin-peroxidase system
(Vector Laboratories Inc., Burlingame, CA, USA) or the immuno-
fluorescent secondary anti-rabbit antibody. Rat aortic rings cultured in
medium were stimulated with 20 ng TNFa/ml for 4 h at 378C, frozen
sections prepared and immunofluorescent staining performed as
described above.
Anti-ICAM-1 antibody
New Zealand white rabbits of mixed sexes were immunized with 0.5 mg
recombinant soluble rat ICAM-1 subcutaneously using Freund’s
complete adjuvant (Lampire Biological Laboratories Inc., Pipersville,
PA, USA). The animals were boostered every 4 weeks until an
acceptable titer (>106) was achieved. The antibody did not demonstrate
cross-reactivity with E-selectin, P-selectin orb-integrins (data not
shown). When used, mouse anti-ICAM-1 monoclonal antibody 1A29
was a gift from Dr. Masayuki Miyasaka (Osaka University, Osaka,
Japan).
Animal model of lung injury
275–300 g male Long-Evans rats (Harlan Industries Inc., Rochester,
MI, USA) were anesthetized with ketamine and lung injury was induced
by intratracheal instillation of 150mg LPS (from E. coli, serotype
055:B5), in 300ml PBS via an intratracheal catheter. Animals were
sacrificed at given time points. To prepare lung homogenates, the
vascular and bronchoalveolar areas of lungs were flushed before en bloc
removal of lungs. For immune complex-induced alveolitis, rabbit
polyclonal IgG rich in antibody to BSA (anti-BSA) was used [14].
Rabbit IgG anti-BSA (2.5 mg) in a final volume of 300ml of PBS was
instilled via an intratracheal catheter during inspiration. Immediately
thereafter, 10 mg BSA was injected intravenously.
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Lung homogenates from LPS and IgG immune
complex-injured lungs
LPS lung injury was induced according to the protocol described above.
The rats were sacrificed at 4 h. Lungs homogenized in PBS containing
10 mM 3-[(3-chloramidopropyl)dimethylammonio]-1-propane sulfonate
(CHAPS) (Sigma Co., St. Louis, MO, USA), 20mg/ml aprotinin
(Boehringer Co.) 20mg/ml bestatin (Sigma Co.) [15], 20mg/ml
leupeptin (Boehringer Co.) and 20ml 0.1 M phenylmethylsulfonyl
fluoride (PMSF) (Sigma Co.). The samples were pulse-homogenized
with a homogenizer at maximum speed. The same procedure was
performed with IgG immune complex-injured lungs (0, 2, 4, 6 and 8 h).
The total volume for each lung homogenate was 10 ml.
Isolation of rat alveolar macrophages
Alveolar macrophages were isolated from BAL fluids of rats as
described previously [16]. Anesthetized rats were exsanguinated and a
tracheotomy was performed. The lungs were lavaged 3 times with 10 ml
of PBS, this fluid then being centrifuged at 1500 RPM for 10 min. The
resuspended macrophages were again subjected to centrifugation and
finally diluted to achieve a concentration of 1× 106 cells/ml.
ELISA with lung homogenates
ELISA was performed in a similar way as described earlier [15]. 96 well
plates (Nunc. Co.) were coated with polyclonal antibody 2mg/ml in
binding buffer and incubated overnight. All washing steps were
performed with PBS/0.2% Tween. A blocking step followed, using PBS
containing 1% bovine serum and 0.05% Tween (278C for 30 min).
Standards and samples were loaded and incubated for 1 h at 378C. The
detecting biotinylated antibody was incubated for 1 h at 378C at a
concentration of 1mg/ml. Streptavidin-horseradish peroxidase (Pierce
Co.) was added (0.1 mg/ml, 15 min, 378C) and plates were developed
with O-phenylenediamine dihydrochloride. The reaction was stopped by
addition of sulfuric acid and the optical density determined at 490 nm.
RNA extraction, reverse transcriptase (RT)-PCR, Northern
blot and quantitative analysis of the PCR product
Whole lungs were homogenized, and RNA extracted with RNA
solubility buffer (RNAZOL) (Gibco-BRL Co. Inc.) according to
previous studies [17]. RNA was purified over oligo-dT cellulose
(Invitrogen Inc.). The final amount of mRNA isolated was between 5
and 30mg. RT-PCR was performed according to the protocol described
in the cDNA-cycle kit (Invitrogen Inc.). In the case of whole-lung
mRNA, the reaction was performed with oligo-dT primers and with
random primers when cDNA was used as the starting material. The
reaction was carried out for two 1-h cycles at 428C with avian
myeloblastosis virus (AMV) reverse transcriptase. The final product
was precipitated using yeast-tRNA as carrier and resuspended in 30ml
double distilled water.
The PCR amplifications were performed using 1.5 Units Taq
polymerase (Gibco Inc.), 50mM dNTPs (nucleoside triphosphate),
2 mM magnesium chloride and 1ml of the different dilutions of cDNA
templates. The total reaction volume was 50ml in each MicroAmpTM
Reaction Tube (Perkin Elmer Co., Norwalk, CT, USA). All amplifica-
tion and hybridization reactions were performed in a GeneAmpy PCR
System 9600 (Perkin Elmer Co.). The following PCR primers with the
corresponding annealing temperatures were used:
Biotin-50-ATGGCTTCAACCCGTGCCAGGC-30 and 50-TCAGG-
GAGGCGGGGCTTGTAC-30, 648C
Amplification protocols utilized the following conditions: 30 cycles
at 948C for 30 s, specific annealing temperature for 1 min, and at 728C
for 1 min, followed by a final incubation at 728C for 10 min. For the
Noerhern blot 12mg total RNA was electrophoresed in a 1.5% agarose
gel containing formaldehyde and transferred to a nylon membrane. The
blot was hybridized overnight with 1:5 × 107 cpm (32P(dCTP)) labeled
oligonucleotides using previously described methods [18]. The
quantitative analysis of the PCR product required hybridization of the
products with oligonucleotides, labelled with tris 2,2 (bipyridine
ruthenium (II) chelate (TBR). A bead capture reaction was used and
electrochemiluminescence PCR products were quantitated in the QPCR
System 5000TM (Perkin Elmer Co.). Hybridization reactions were
carried out using the following temperature program: 948C for 2 min to
denature the PCR product and 558C for 3 min to hybridize the
biotinylated strand with the TBR-labeled oligonucleotide. The
sequence for the TBR-labeled probes were as follows:
TBR-50-CAGTGTCTCATTCCCACGGAG-30, 648C.
The hybridization reaction contained 2–4ml of the PCR product,
10–20 pM of TBR-labeled probe and hybridization buffer in a final
volume of 50ml. For the bead capture reaction, 15ml or 30ml of a 2mg/
ml 4.5mm magnetic polystyrene bead suspension (Dynabeads M450,
Dynal Co., Great Neck, NY, USA) was added directly in the PCR
tube. The capture reaction was carried out for 20 min at 558C.
Thereafter the whole reaction mix was immediately transferred to a
separate quick PCR (QPCR) System 5000 tube for measurement of the
electrochemiluminescent signal.
Statistical analysis
All experiments were performed in duplicate. Data were analyzed by
two-tailed Student’s t-test. Data were considered statistically significant
if p-values were less than 0.05.
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Fig. 1. pLysS bacteria were stimulated and analyzed at different
densities (determined by O.D.) for different time periods (h). The
soluble products were analyzed on 15% SDS/PAGE (A). The first three
lanes were samples from bacteria suspensions with an optical density
(O.D.) of 0.7, stimulated for 1 h (lane 1), 2 h (lane 2) and 3 h (lane 3). In
lanes 4–6 (O:D: ¼ 0:7) and 7–9 (O:D: ¼ 0:8), stimulation was for 2 or
3 h. There was an increase of protein expression with time. The O.D. of
a given sample did not seem to correlate with protein expression. In
further studies using 15% SDS/PAGE, products were eluted with three
different concentrations of imidazole under nonreducing and reducing
conditions (B). The following elution conditions (including imidazole
concentrations) were employed: lane 1: 100 mM, nonreducing; lane 2:
100 mM reducing; lane 3: 200 mM, nonreducing; lane 4: 200 mM,
reducing; lane 5: 300 mM, nonreducing; lane 6: 300 mM reducing.
m
Results
Expression of soluble rat ICAM-1 in a bacterial system
A rat ICAM-1 expression vector was created by ligating a
618 bp cDNA containing the ICAM-1 binding CD11a/CD18
sites for (LFA-1) and CD11b/CD18 (Mac-1) into pET and
pPBac vectors. This cDNA was about one fourth the full
length of ICAM-1 (2680 bp). The chances to obtain a soluble
protein were increased with this construct. Sequencing of the
construct demonstrated the correct orientation of the insert in
the vector. Our 618 bp cDNA construct was totally identical
(data not shown) with the same region of the full rat ICAM-1
construct (2680 bp), the sequence of which has already been
published [7]. After transformation intoE. coli pLysS, the
cells were stimulated with IPTG (0.4 mM final concentra-
tion) for 1, 2 and 3 h. Bacteria were lysed and the fractions
analyzed by SDS/PAGE. Maximum expression of protein
was found at 3 h (Fig. 1A). Purification of the soluble protein
was performed using three different elution concentrations of
imidazole (Fig. 1B). As seen in the Coomassie gel, the best
yield was with 200 mM imidazole (lanes 3, 4). In bacterial
cultures, the final concentration of ICAM-1 was 0.5 mg/liter.
The insoluble ICAM-1 was purified and eluted with the same
buffers containing 6 M urea. Both proteins were in position
at 24 kDa instead of expected 23 kDa position, due to the
presence of the polyhistidine tail.
Expression of soluble ICAM-1 by insect cells
Using the 618 bp PCR product and the pPBac vector, a
transfer vector was created. In contrast to a previous study
with human ICAM-1 in which several constructs were found
to be expressed [19], only one construct was expressed by the
baculovirus expression system in this study. The main
objective was aimed at developing a polyclonal antibody
rather than a functionally active protein. Western blot
analysis of cell products obtained using recombinant virus
or a wildtype virus (control) demonstrated the expressed
protein to be of the correct size (Fig. 2, lane 1). The control
virus did not yield a product detected by Western blot
analysis (Fig. 3, lane 2). Low molecular weight markers are
shown in lane 3. The protein was purified by dialyzing
and using an affinity column loaded with the antibody to
ICAM-1. As described elsewhere, the insect cell system is
very effective in generating large quantities of proteins
[19, 20] along with a functionally active protein [21]. We
achieved 2 mg soluble ICAM-1/liter using these methods.
This material was employed for the generation of rabbit
polyclonal antibody.
Quantitation of ICAM-1 expression in vitro
Western blot analysis was performed to determine if the
polyclonal antibody recognized the same protein as the
monoclonal 1A29 anti-ICAM-1 antibody [15]. Usingwhole
lung homogenates from 4 h inflamed rat lungs as a source for
full length rat ICAM-1, both antibodies recognized the same
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Fig. 2. Western blot analysis using polyclonal anti-ICAM-1 antibody.
Using 15% SDS/PAGE, lysed, infected insect cells products were
transblotted and Western analysis performed. Lane 1 shows protein
expression of ICAM-1 by baculovirus at the 23 kDa position; lane 2
fails to show protein expression in material obtained from uninfected
cells; lane 3 contains the low molecular weight marker.
Fig. 3. Immunohistochenmical staining of unstimulated RPAEC.
Staining for constitutive ICAM-1 expression was visible (A); with
stimulation by TNFa (50 ng/ml), ICAM-1 expression increased (B).
m
protein with the size of 97 kDa (data not shown). This size is
consistent with previously published data [22], with a band
of 91–97 kDa position. For immunostaining of RPAEC, cells
were stimulated for 4 h in the presence or absence of murine
TNFa (50 ng/ml). In Fig. 3A in which the newly prepared
rabbit anti-ICAM-1 IgG was used, the staining of non-
stimulated cells was found, apparently detecting constitutive
ICAM-1. In Fig. 3B more intense staining for ICAM-1 was
detected. Quantitation of these differences in ICAM-1
content is described below.
Immunofluorescence staining was performed on frozen
sections of rat aortic rings which were stimulated in vitro
with TNFa (20 ng/ml for 4 h). Fig. 4 shows the staining of a
stimulated aortic ring for ICAM-1. The endothelial surface
stained intensely, but, there was also some staining of
smooth muscle cells. ICAM-1 expression on vascular
smooth cells has been described previously [23]. Control
(non-stimulated) rings did not show evidence of fluorescence
(data not shown). When LPS was used to stimulate RPAEC,
there was a significant increase (50%) in ICAM-1 content,
reaching a plateau after 6 h (Fig. 5A). Using different
LPS concentrations, ICAM-1 expression on RPAEC was
maximal at the LPS concentration of 10mg/ml (Fig. 5B).
Monolayers of alveolar macrophages from normal rat
lungs were prepared using 96 well plates and stimulated with
increasing concentrations of TNFa (0–100 ng/ml). The time
course for LPS-induced expression of ICAM-1 on alveolar
macrophages showed a plateau at 2 h (70% increase)
(Fig. 6A). Maximal stimulation (40% increase) in ICAM-1
expression was reached at 10 ng TNFa/ml (Fig. 6B).
Quantitation of ICAM-1 mRNA and protein expression
in vivo
Homogenates from IgG immune complex-injured lungs were
evaluated by Northern blot analysis and with quantitative
PCR at 0, 2, 4, 6 and 8 h after initiation of the inflammatory
reactions. As expected, by Northern blot analysis low
constitutive expression of ICAM-1 mRNA was found in
normal lungs, with a 12-fold upregulation 4 h after initiation
of the reactions (Fig. 7A). A comparison of Northern blot
analysis to quantitative PCR is shown in Fig. 7 (A, B). By 6 h
of lung injury, ICAM-1 mRNA as assessed by quantitative
PCR decreased to baseline levels. Data derived from the two
methods of mRNA measurement were reasonably compar-
able. To determine whole lung ICAM-1 protein content,
lungs were homogenized at indicated time points and ELISA
performed. The greatest increase in total ICAM-1 protein
was demonstrated at 6 h (Fig. 7C), following the earlier
increase in mRNA for ICAM-1. As indicated above, at least
two different cell sources for lung ICAM-1 have been
identified: alveolar macrophages and vascular endothelial
cells.
Discussion
Rat ICAM-1 was expressed in order to develop an ELISA
for measurement of ICAM-1 protein as well as to raise
a polyclonal antibody for further direct protein studies.
ICAM-1 was expressed in vitro in two different systems. In
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Fig. 4. Immunofluorescence staining of TNFa-stimulated rat aortic
ring, showing expression of ICAM-1 on endothelial and smooth muscle
cells.
Fig. 5. Time course for ICAM-1 expression in LPS-stimulated (10mg/
ml) RPAEC (A). Maximum expression was found at 6 h. RPAEC
stimulated with increasing concentrations of LPS (0–50mg/ml) (B).
Maximum expression was found when the concentration of LPS was
10mg/ml).
m
comparing the bacterial pET and the baculovirus expression
systems, the latter revealed a higher yield and purity but was
much more time-consuming. The baculovirus system,
however, may have advantages over the pET system with
regard to the function of the expressed protein due to post-
translational modifications of the protein in the insect cells.
Successful purification of a membrane-bound protein begins
with selection of an appropriate detergent and establishment
of the solubilization conditions [24]. We found that CHAPS
was best detergent-suited for our purposes because it was
milder than a detergent like SDS, which tended to activate
proteases, resulting in cleavage of ICAM-1. To prevent
proteolysis, a mixture of bestatin, leupeptin, aprotinin and
PMSF was used. This technique of protein extraction from
lung tissue has become a common procedure and has been
repeatedly used [18]. When ICAM-1 content was evaluated
in whole lung homogenates, in the absence of this mixture of
inhibitors, Western blots consistently showed an ICAM-1
species considerably below the expected 97 kDa position
(data not shown).
Endothelial (RPAEC) ICAM-1 expression in vitro was
assessed in RPAEC. Following LPS stimulation (5mg/ml)
for 2, 4, 6 and 8 h, a plateau in expression of protein being
found after 6 h. In contrast to these in vitro results, in LPS-
injured lungs in vivo, ICAM-1 message peaked at 4 h while
protein expression was detected at 2 h but persisted for
as long as 8 h [15]. Similar results have been obtained
with TNFa stimulated human umbilical vein endothelial
cells (HUVEC) [13, 25]. In the study by Wertheimer et al.
[25] there was an early (2 h) peak and followed later by a
plateau for ICAM-1 mRNA expression in TNFa-stimulated
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Fig. 6. Expression of ICAM-1 in rat alveolar macrophages. Maximum
expression was reached after 2 h (A). Using a dose range of TNFa with
the end-point of 2 h, maximal expression of ICAM-1 occurred at a dose
of TNFa of 10 ng/ml (B).
Fig. 7. Northern blot analysis with mRNA for ICAM-1 in a time-course
for IgG immune complex-induced lung injury (A). Similar analysis was
carried out using quantitative PCR (B). ICAM-1 protein content in
whole lung homogenates was measured by ELISA (C).
m
HUVEC. We saw a similar pattern of ICAM-1 expression in
rat alveolar macrophages, with a plateau after 2 h of
stimulation [15]. When canine alveolar macrophages were
stimulated in vitro with LPS over 24 h, there was a steady
increase of ICAM-1 expression [26]. This result could be due
to the difference in LPS concentration used (5 ng/ml versus
5mg/ml in our studies). At the higher concentration, the
macrophages appeared to be maximally stimulated, which
may have resulted in earlier down-regulation of the ICAM-1
response.
The quantitative PCR method used in this study
correlated well with the data obtained by Northern blot
analysis and offers the significant advantage for more
accurate quantitation of mRNA levels rather than assessing
relative expression levels [27, 28]. The electrochemilumi-
nescence detection of PCR products was time-efficient and
highly specific due to the TBR-labeled oligonucleotides and
provides a valuable tool for evaluation of mRNA regulation
[29, 30].
Interestingly, there was only a slight increase of ICAM-1
expression in the endothelial cell cultures compared to in
vivo ICAM-1 upregulation in whole lungs. This could
have several explanations: 1) in cell culture, there is no
interaction between different cell types, this interaction
being required for optimal expression of ICAM-1; 2) apart
from endothelial cells or alveolar macrophages, other cells,
such as epithelial cells, may contribute to the total
production of ICAM-1 in the lung; 3) in cell culture with
confluent monolayers, only the apical part of the cell is
studied with ELISA techniques, omitting the basolateral area
of the cell. In conclusion, soluble rat ICAM-1 was expressed
in two different expression systems and a new polyclonal
antibody was generated. The cDNA, the recombinantly
expressed ICAM-1, and the polyclonal antibody developed
represent useful tools in the elucidation of the role of this
adhesion molecule. These reagents have permitted a detailed
analysis rat ICAM-1 expression in inflammatory processes.
Expanding these studies should add additional information in
characterizing the role of ICAM-1 expression in lung
inflammation.
References
[1] Barton RW, Rothlein R, Ksiazek J, Kennedy C. The effect of
anti-intercellular adhesion molecule-1 on phorbol-ester-induced
rabbit lung inflammation. J Immunol 1989;143:1278–82.
[2] Mulligan MS, Wilson GP, Todd RF, Smith CW, Anderson DC,
Varani J, et al. Role of beta 1, beta 2 integrins and ICAM-1 in lung
injury after deposition of IgG and IgA immune complexes. J
Immunol 1993;150:2407–17.
[3] Seekamp A, Mulligan MS, Till GO, Smith CW, Miyasaka M,
Tamatani T, et al. Role of beta 2 integrins and ICAM-1 in lung
injury following ischemia-reperfusion of rat hind limbs. Am J
Pathol 1993;143:464–72.
[4] Albelda SM. Endothelial and epithelial cell adhesion molecules.
Am J Respir Cell Mol Biol 1991;4:195–203.
[5] Ward PA, Mulligan MS, Vaporciyan AA, Eppinger MJ. Adhe-
sion molecules in experimental lung inflammatory injury. In:
Ward PA, Fantone JC, editors. Adhesion molecules and the
lung. New York, Basel, Hong Kong: Marcel Drekker,
1996:150–76.
[6] Wawryk SO, Novotny JR, Wicks IP, Wilkinson D, Maher D,
Salvaris E, et al. The role of the LFA-1/ICAM-1 interaction
in human leukocyte homing and adhesion. Immunol Rev
1989;108:135–61.
[7] Kita Y, Takashi T, Iigo Y, Tamatani T, Miyasaka M, Horiuchi T.
Sequence and expression of rat ICAM-1. Biochem Biophys Acta
1992;1131:108–10.
[8] Miller LK. Baculoviruses as gene expression vectors. Annu Rev
Microbiol 1988;42:177–99.
[9] Smith GE, Summers MD, Fraser MJ. Production of human beta
interferon in insect cells infected with a baculovirus expression
vector. Biotechnology 1992;24:434–43.
[10] Jones ML, Mulligan MS, Flory CM, Ward PA, Warren JS.
Potential role of monocyte chemoattractant protein 1/JE in
monocyte/macrophage-dependent IgA immune complex alveolitis
in the rat. J Immunol 1992;149:2147–54.
[11] Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: A
laboratory manual. Cold Spring Harbor: Cold Spring Harbor
Lab., 1982:73–82.
[12] Laemmli UK. Cleavage of structural proteins during the assembly
of the bacteriophage T4. Nature 1970;227:680–5.
[13] Muligan MS, Vaporciyan AA, Miyasaka M, Tamatani T, Ward
PA. Tumor necrosis factora regulates in vivo intrapulmonary
expression of ICAM-1. Am J Pathol 1993;142:1739–49.
[14] Johnson KJ, Ward PA. Acute immunologic pulmonary alveolitis.
J Clin Invest 1974;54:349–57.
[15] Beck-Schimmer B, Schimmer RC, Warner RL, Schmal H,
Nordblom G, Flory CM, et al. Expression of lung vascular and
airway ICAM-1 after exposure to bacterial lipopolysaccharide.
Am J Respir Cell Mol Biol 1997;17:344–52.
[16] Ward PA, Duque RE, Sulavik MC, Johnson KJ. In vitro and in
vivo stimulation of rat neutrophils and alveolar macrophages by
immune complexes. Production of O2- and H2O2. Am J Pathol
1983;110:297–309.
[17] Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ. Isolation
of biologically active ribonucleic acid from sources enriched in
ribonuclease. Biochemistry 1979;18:5294–9.
[18] Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA. Regula-
tory effects of intrinsic IL-10 in IgG immune complex-induced
lung injury. J Immunol 1995;154:3453–60.
[19] Cobb RR, Dubins JS, Warner J, Molony L. Functional expression
of soluble ICAM-1 by baculovirus-infected Sf9 cells. Biochem
Biophys Res Commun 1985;185:1022–33.
[20] Zhao Y, Sane DC. Expression of a recombinant baculovirus for
vitronectin in insect cells: Purification, characterization of
posttranslational modifications and functional studies of the
recombinant protein. Arch Biochem Biophys 1993;304:434–42.
[21] Shridhar P, Hasnain SE. Differential secretion and glycosylation
of recombinant human chorionic gonadotropin (bhCG) synthe-
sized using different promoters in the baculovirus expression
vector system. Gene 1993;131:261–4.
[22] Tamatani T, Miyasaka M. Identification of monoclonal antibodies
reactive with the rat homolog of ICAM-1, and evidence for a
differential involvement of ICAM-1 in the adherence of resting
versus activated lymphocytes to high endothelial cells. Int
Immunol 1990;2:165–71.
[23] Ikeda U, Ikeda M, Seino Y, Takahashi M, Kasahara T, Kano S,
et al. Expression of intercellular adhesion molecule-1 on rat
vascular smooth muscle cells by pro-inflammatory cytokines.
Atherosclerosis 1993;104:61–8.
[24] Hjelmeland LM. Solubilization of native membrane proteins.
Methods Enzymol 1990;182:253–64.
[25] Wertheimer SJ, Meyers CL, Wallace RW, Parks TP. Intercellular
adhesion molecule-1 gene expression in human endothelial cells. J
Biol Chem 1992;267:12030–5.
[26] Grigg J, Kukielka GL, Berens KL, Dreyer WJ, Entman ML,
Smith CW. Induction of intercellular adhesion molecule-1 by
lipopolysaccharide in canine alveolar macrophages. Am J Respir
Crit Care Med 1994;11:304–11.
[27] Dallman MJ, Montgomery MJ, Larsen CP, Wanders A, Wells
AF. Cytokine gene expression: Analysis using Northern blotting
polymerase chain reaction and in situ hybridization. Immunol Rev
1995;119:163–79.
314 B. Beck-Schimmer et al. Inflamm. res.
m
[28] Salomon RN, Underwood R, Doyle MV, Wang A, Libby P.
Increased apolipoprotein E and c-fms gene expression without
elevated interleukin 1 or 6 mRNA levels indicates selective
activation of macrophage functions in advanced human atheroma.
Proc Natl Acad Sci 1987:7160–4.
[29] Kenten JH, Gudibande S, Link J, Willey JJ, Curfman B, Major
EO, et al. Improved electrochemiluminescent label for DNA probe
assays: Rapid quantitative assays of HIV-1 polymerase chain
reaction products. Clin Chem 1992;38:873–9.
[30] DiCesare J, Grossmann B, Katz E, Picozza E, Ragusa R,
Woudenberg T. A high-sensitivity electrochemiluminescence-
based detection system for automated PCR product quantitation.
Biotechniques 1993;15:152–7.
315Vol. 47, 1998 Rat lung ICAM-1
m
